Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea is the most commonly reported side effect of tirzepatide. In the SURMOUNT-1 trial, roughly one in five participants on the highest doses experienced nausea at some point during treatment, with symptoms most frequent in the early weeks and after each dose step-up. It is uncomfortable, but for most people it is temporary and manageable — and it does not mean the medicine is harming you. Mounjaro (tirzepatide) is a prescription-only medicine that slows how quickly your stomach empties food into the small intestine. That slower transit is part of how it reduces appetite. It also means your stomach can feel fuller, heavier or unsettled for longer than usual, particularly while your body is still adjusting. The good news is that the evidence consistently shows nausea tends to ease within a few days to two weeks of starting a new dose.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide works at two gut-hormone receptors, GIP and GLP-1, both of which play a role in regulating how your body processes food and signals fullness to the brain. One of those signals involves slowing gastric emptying, the rate at which your stomach moves food downwards. According to the NHS tirzepatide medicines page, nausea, vomiting, diarrhoea and constipation are all listed among the common side effects, and all of them trace back to that same altered digestive rhythm. Your stomach is used to clearing meals at a certain pace. When that pace slows, the stomach wall stretches for longer, acid has more time to build, and the result can be a persistent low-grade sickness that is hard to pinpoint as hunger or nausea. It tends to feel worse first thing in the morning or shortly after eating.
The same mechanism that causes the discomfort is also what makes the medicine effective, appetite falls partly because you feel full from a smaller meal for far longer. Understanding that connection helps. You are not having a bad reaction in the toxic sense. Your digestive system is recalibrating.
Fatigue sometimes travels alongside nausea in the early weeks; there is a separate explanation on why tiredness happens on Mounjaro if that is also affecting you.
The structured dose-escalation schedule exists precisely because higher doses cause more pronounced gastric effects. Starting at 2.5mg gives your body a lower-intensity introduction to the mechanism before the dose climbs. Each step up restarts a short adjustment window. Clinical trial data from the SURMOUNT programme, summarised in NICE's technology appraisal TA1026, shows that gastrointestinal side effects were most common during the early dose-escalation phases and declined with time at each level.
In practice, many people notice that the third week of a new dose is the worst, their body has been at the new level long enough for the effect to be fully established, but has not yet adapted. If that description fits your experience, the week-three side-effect pattern is worth reading. The nausea associated with dose increases is also the reason prescribers sometimes hold a dose for longer than four weeks if symptoms are significant, something to raise at your next clinical review rather than manage in silence.
Headaches can accompany nausea, often linked to reduced food and fluid intake. The Mounjaro headache page covers that separately.
Several practical adjustments have consistent backing from clinical guidance and prescriber experience. Eat smaller portions than you normally would; tirzepatide-level satiety arrives much faster than your pre-treatment brain expects, and overfilling a stomach that is already emptying slowly is the fastest route to feeling sick. Eat slowly. Prioritise protein and vegetables over high-fat, fried or very rich meals, fat delays gastric emptying further, compounding the drug's own effect. If you inject in the evening, your pen is probably sitting in the fridge door next to tonight's leftovers, keeping the injection time consistent (and separate from your largest meal) can help some people establish a pattern that their stomach tolerates better.
Stay well hydrated between meals rather than drinking large amounts with food. Ginger in any form (tea, biscuits, capsules) has reasonable evidence for reducing nausea generally and many people find it helps. Avoid lying down immediately after eating. On days when nausea is bad, plain foods like crackers, toast or rice are easier to tolerate than anything rich.
There is more detail on this at managing nausea after meals on Mounjaro, including guidance on what to do if eating has become difficult. The full side-effect overview also covers the broader picture beyond nausea.
Most nausea on tirzepatide is unpleasant but self-limiting. There are circumstances where it requires more than patience. Vomiting that lasts more than 24 hours, or that prevents you keeping any food or fluid down, risks dehydration and needs medical attention. Severe stomach pain that radiates to your back (with or without vomiting) is a separate and more serious concern; the MHRA has highlighted acute pancreatitis as an infrequent but known risk with GLP-1 medicines, and that symptom pattern warrants prompt assessment by a doctor. You can report any suspected side effect to the MHRA Yellow Card scheme directly.
If nausea is making treatment feel unsustainable, that is a clinical conversation, not a reason to stop quietly. A prescriber can advise on whether a dose adjustment, a longer hold, or a different injection timing might help. People who feel persistently unwell on Mounjaro sometimes assume they simply cannot tolerate it, but the cause is often something adjustable. The detailed guide to managing sickness on Mounjaro covers what those conversations typically involve. If you have further questions about how the medicine works, the FAQs may also help. And if you are considering starting treatment or want a prescriber to review how things are going, speaking to the team at nume is the right next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.